2B93.0

ICD-11 MMS 2026-01

Adenocarcinoma of large intestine, site unspecified

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Index terms

  • Adenocarcinoma of large intestine, site unspecified
  • adenocarcinoma of overlapping lesion of large intestine

Exclusions from above levels

  • http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
  • http://id.who.int/icd/entity/111033337 – Malignant neoplasm metastasis in digestive system
  • http://id.who.int/icd/entity/794095161 – Malignant neoplasms of lip, oral cavity or pharynx
Show allHide
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2B93.Y – Other specified malignant neoplasms of large intestine, site unspecified
  • 2B93.Z – Malignant neoplasms of large intestine, site and type unspecified

Foundation entity

Adenocarcinoma of large intestine, site unspecified – http://id.who.int/icd/entity/59190475

Allowed postcoordination axes

Part of: 2B93: Malignant neoplasms of large intestine, site unspecified › 02: Neoplasms